中国医药科学Issue(11)：76-77,2.
注射用重组人干扰素α2b联合胸腺肽肠溶片治疗慢性乙型肝炎48例
Study on injection of recombinant human interferon alpha 2b combined with thymosin enteric-coated tablets in treatment of 48 cases of chronic hepatitis B
丁慧俊 1殷思纯 1曹焕焕 1何松美1
作者信息
- 1. 广东省东莞市人民医院感染内科，广东东莞523000
- 折叠
摘要
Abstract
Objective To investigate the effect of recombinant human interferon alpha 2b combined with thymosin enteric-coated tablets in the treatment of chronic hepatitis B. Methods 96 cases of chronic hepatitis B patients were divided into the observation group and the control group. The control group was treated with recombinant human interferon alpha 2b. The observation group were treated with recombinant human interferon alpha 2b combined with thymosin enteric-coated tablets. Results The total effective rate of the observation group was 79.17% higher than 60.42% in the control group, significant difference (P < 0.05). Conclusion Effects of treating chronic hepatitis B with recombinant human interferon alpha 2b combined with thymosin enteric-coated tablets well.关键词
重组人干扰素α2b/胸腺肽肠溶片/慢性乙型肝炎Key words
Recombinant human interferon alpha 2b/Thymosin enteric-coated tablets/Chronic hepatitis B分类
医药卫生引用本文复制引用
丁慧俊,殷思纯,曹焕焕,何松美..注射用重组人干扰素α2b联合胸腺肽肠溶片治疗慢性乙型肝炎48例[J].中国医药科学,2013,(11):76-77,2.
